Status:
COMPLETED
Rosiglitazone and Insulin in T1DM Adolescents
Lead Sponsor:
The University of New South Wales
Collaborating Sponsors:
Sydney Children's Hospitals Network
National Health and Medical Research Council, Australia
Conditions:
Type 1 Diabetes
Puberty: >Tanner 2 Breast Development or Testis >4ml
Eligibility:
All Genders
10-18 years
Phase:
PHASE4
Brief Summary
Type 1 Diabetes is the most common life-long disorder with onset in childhood. Patients need insulin injections, blood sugar monitoring several times each day, and adhere to a strict diet. Adequate co...
Eligibility Criteria
Inclusion
- T1DM duration \> 1year
- age 10-18years
- HbA1c \> 8%
- puberty \> Tanner stage 2 breast or testis \>4ml
Exclusion
- known non-compliance
- hypo unaware
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00372086
Start Date
August 1 2003
End Date
September 1 2005
Last Update
September 6 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sydney Children's Hospital
Sydney, New South Wales, Australia, 2038